Viemed Healthcare, Inc. — Earnings Quality Grade C
VMD · Healthcare
Some red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 35 days, change -6 days YoY
AR growth 2.7% vs revenue growth 20.5%
Revenue 20.5%, CFFO 32.8%. Cash follows revenue
Expense Quality
Inventory 16.8% vs COGS 26.1%. Normal
CapEx growth 5.9% vs revenue 20.5%. Normal
SG&A/Gross Profit = 83.9%, exceeds 70%
Gross margin 57.5%, change -1.9pp. Stable
Cash Flow Quality
CFFO/NI = 3.48. Profits backed by cash
FCF $0.0B, FCF/NI = 0.80
Accruals ratio = -18.6%. Low accruals
Cash $0.0B covers 85% of debt $0.0B
Balance Sheet Health
Goodwill+Intangibles $0.1B = 43% of equity
Debt/EBITDA = 0.3x. Healthy
Insufficient data
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
Goodwill+Intangibles surged 78% YoY
Manipulation Score
M-Score = -3.19 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor VMD continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25